We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTG icon
701
B2Gold
BTG
$5.16B
$465K 0.01%
+166,200
New +$495K
WEN icon
702
Wendy's
WEN
$1.39B
$465K 0.01%
+26,000
New +$442K
HELE icon
703
Helen of Troy
HELE
$658M
$464K 0.01%
4,000
– –
SKT icon
704
Tanger
SKT
$4.8B
$462K 0.01%
22,000
– –
WIT icon
705
Wipro
WIT
$18.9B
$460K 0.01%
231,364
-1
-0% -$2
COTY icon
706
Coty
COTY
$2.39B
$459K 0.01%
39,891
-850,563
-96% -$8.04M
THG icon
707
Hanover Insurance
THG
$7.68B
$457K 0.01%
+4,000
New +$461K
JBHT icon
708
JB Hunt Transport Services
JBHT
$26.4B
$456K 0.01%
+4,506
New +$467K
FSM icon
709
Fortuna Silver Mines
FSM
$2.59B
$453K 0.01%
+135,950
New +$503K
ANDE icon
710
Andersons Inc
ANDE
$2.54B
$451K 0.01%
+14,000
New +$485K
CGNX icon
711
Cognex
CGNX
$10.2B
$451K 0.01%
8,859
+248
+3% +$11.9K
HBI
712
DELISTED
Hanesbrands
HBI
$451K 0.01%
+25,206
New +$419K
SPY icon
713
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$446K 0.01%
+1,100
New +$299K
EAT icon
714
Brinker International
EAT
$8.38B
$444K 0.01%
10,000
– –
SLGN icon
715
Silgan Holdings
SLGN
$4.92B
$444K 0.01%
+15,000
New +$414K
DDS icon
716
Dillards
DDS
$8.96B
$432K 0.01%
+6,000
New +$413K
SHOP icon
717
Shopify
SHOP
$165B
$428K 0.01%
20,740
– –
UMC icon
718
United Microelectronic
UMC
$47.9B
$426K 0.01%
226,796
– –
INGR icon
719
Ingredion
INGR
$6.4B
$408K 0.01%
4,310
+310
+8% +$29.3K
CHDN icon
720
Churchill Downs
CHDN
$6.15B
$406K 0.01%
9,000
– –
JACK icon
721
Jack in the Box
JACK
$299M
$405K 0.01%
5,000
– –
MCY icon
722
Mercury Insurance
MCY
$6.01B
$401K 0.01%
8,000
– –
OMED
723
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$395K 0.01%
380,000
– –
CAE icon
724
CAE Inc. Common Shares
CAE
$8.3B
$393K 0.01%
17,724
-15,377
-46% -$322K
SKM icon
725
SK Telecom
SKM
$13.5B
$390K 0.01%
9,663
– –
27 28
29
30 31

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.